Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
about
TAMH: A Useful In Vitro Model for Assessing Hepatotoxic MechanismsLiver tissue engineering in the evaluation of drug safety.Bis(hydroxyphenyl)methane-bisphenol F-metabolism by the HepG2 human hepatoma cell line and cryopreserved human hepatocytes.Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening.Organotypic liver culture models: meeting current challenges in toxicity testing.Functional evolution of the pregnane X receptor.Luminogenic cytochrome P450 assays.A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro.Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.Microfluidic platforms for hepatocyte cell culture: new technologies and applications.Cell patterning for liver tissue engineering via dielectrophoretic mechanisms.Drug metabolism and drug interactions: potential application to antituberculosis drugs.Growth and Development Symposium: Development, characterization, and use of a porcine epiblast-derived liver stem cell line: ARS-PICM-19.Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence.Microstructuring of multiwell plates for three-dimensional cell culture applications by ultrasonic embossing.Development of a whole-cell screening system for evaluation of the human CYP1A2-mediated metabolism.Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.Perfusion of 3D encapsulated hepatocytes-A synergistic effect enhancing long-term functionality in bioreactors
P2860
Q28818435-373B65F2-B778-4BCB-B38D-87BA4351A93DQ33950022-7535560C-000A-4542-B14D-5539E7A985AAQ34201779-9C794A2A-4C1D-4199-985B-3473E3229D1AQ34663837-234D28E4-5E78-429F-BF9E-E71C721AECB6Q36178225-5B102EFA-D8C3-4402-8789-A479C4D93F44Q36440155-6B4B3B99-2B64-4B87-87BC-886AC2A57EFAQ36543124-7D3ECA94-3968-4B32-BA8E-48CFC8BEFDFEQ37527804-CC494A6F-B3EE-4B49-B56B-6998781F5DFEQ37579509-5B469741-1FEA-49FB-85CF-9297B3F17762Q37951402-4FE0D49B-F020-48B2-8922-55E87D0D5ACAQ38225910-1BC796DA-9C25-41D8-B6D4-949493B5E4D0Q38502286-443AB474-C4E2-407F-BB4B-8E365AF1D7DFQ39245521-F84A8B26-5792-4699-A56F-24A4666787C7Q39389259-1CE8F0D2-4458-4FFF-A76B-5596EE9BD307Q39446105-9632EE8D-C515-4A03-8AE1-385C86F3BCBAQ39507022-B68727F0-4ECA-4880-96F8-2E0DF9EB0DE9Q39920320-A0C4D2DA-3F71-4F54-9BB0-0A20F694A9C4Q43064767-97C2B2D1-5791-499F-9FAB-96E9C4F01DD1Q58754027-9448E758-9B83-4462-98DD-F47B18E8F900
P2860
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@ast
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@en
type
label
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@ast
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@en
prefLabel
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@ast
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@en
P2093
P2860
P356
P1476
Cell-based models to study hepatic drug metabolism and enzyme induction in humans.
@en
P2093
Dirk Roymans
Geert Mannens
Marc Vermeir
Pieter Annaert
Rao N V S Mamidi
Willem Meuldermans
P2860
P356
10.1517/17425255.1.1.75
P407
P577
2005-06-01T00:00:00Z